Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewBTZO 1
Description: MIF binder
Chemical Name: 2-(2-Pyridinyl)-4H-1,3-benzothiazin-4-one
Purity: ≥99% (HPLC)
Biological Activity for BTZO 1
BTZO 1 binds macrophage migration inhibitory factor (MIF; Kd = 68.6 nM) and activates antioxidant response element (ARE)-mediated gene expression. BTZO 1 suppresses oxidative stress-induced cardiomyocyte apoptosis in vitro and is cardioprotective.
External Portal Information for BTZO 1
Chemicalprobes.org and the Chemical Probes webpages of the Structural Genomics Consortium are portals that offer independent guidance on the selection and/or application of small molecules for research. The use of BTZO 1 is reviewed on chemicalprobes.org and the SGC website.
Compound Libraries for BTZO 1
BTZO 1 is also offered as part of the Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.
Technical Data for BTZO 1
| M. Wt | 240.28 |
| Formula | C13H8N2OS |
| Storage | Store at RT |
| Purity | ≥99% (HPLC) |
| CAS Number | 99420-15-2 |
| PubChem ID | 9837640 |
| InChI Key | GBAKVEWPYUIGHN-UHFFFAOYSA-N |
| Smiles | O=C2C1=CC=CC=C1SC(C3=NC=CC=C3)=N2 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for BTZO 1
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 4.81 | 20 with gentle warming |
Preparing Stock Solutions for BTZO 1
The following data is based on the product molecular weight 240.28. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 20.81 mL | 104.05 mL | 208.09 mL |
| 1 mM | 4.16 mL | 20.81 mL | 41.62 mL |
| 2 mM | 2.08 mL | 10.4 mL | 20.81 mL |
| 10 mM | 0.42 mL | 2.08 mL | 4.16 mL |
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets for BTZO 1
References for BTZO 1
References are publications that support the biological activity of the product.
Kimura et al (2010) BTZO-1, a cardioprotective agent, reveals that macrophage migration inhibitor factor regulates ARE-mediated gene expression. Chem.Biol. 17 1282 PMID: 21168764
If you know of a relevant reference for BTZO 1, please let us know.
View Related Products by Target
Keywords: BTZO 1, BTZO 1 supplier, BTZO1, mif, macrophage, migration, inhibitory, factors, binders, binds, cardioprotective, Cytokines, 4204, Tocris Bioscience
Citations for BTZO 1
Citations are publications that use Tocris products.
Currently there are no citations for BTZO 1. Do you know of a great paper that uses BTZO 1 from Tocris? Please let us know.
Reviews for BTZO 1
There are currently no reviews for this product. Be the first to review BTZO 1 and earn rewards!
Have you used BTZO 1?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Rheumatoid Arthritis Poster
Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.